Destiny Pharma (DEST): Corp FY results – FDA clarification – on track | Solid State (SOLI): Corp Year-end trading update

12 Apr 2018
Morning Note

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
12 Apr 2018 -
Author:
Mark Brewer -
Pages:
4 -
Destiny Pharma (DEST): Corp FY results – FDA clarification – on track | Solid State (SOLI): Corp Year-end trading update